Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$88,303,495
-$23,039,423 QoQ
Shares Held
350,912
-31.5% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#269
of 4,150 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $673,665,379 across 15 Drug Manufacturers - General names. ABBV ranks #3 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
222,559 | $266,943,963 | |
| 2 | JNJ |
Johnson & Johnson
|
466,851 | $118,566,148 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
350,912 | $88,303,495 | |
| 4 | MRK |
Merck & Co., Inc.
|
473,483 | $60,842,565 | |
| 5 | AMGN |
Amgen Inc
|
133,818 | $48,458,174 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
238,168 | $30,090,145 | |
| 7 | PFE |
Pfizer Inc
|
1,108,420 | $26,690,753 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
444,025 | $25,584,720 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,303,495 | 350,912 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $111,342,918 | 511,945 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $109,572,836 | 479,552 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $107,354,447 | 463,654 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $83,765,665 | 451,275 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $71,964,043 | 343,471 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $60,217,909 | 338,874 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $67,045,447 | 339,505 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $57,045,150 | 332,586 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $76,373,286 | 419,403 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $63,940,622 | 412,600 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $60,458,586 | 405,599 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $54,227,477 | 402,490 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $63,353,399 | 397,524 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $62,950,327 | 389,520 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $47,659,715 | 355,113 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $50,484,905 | 329,622 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $54,829,492 | 338,224 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $41,883,146 | 309,329 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $30,760,964 | 285,167 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $37,785,989 | 335,458 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $35,180,482 | 325,083 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $34,847,215 | 325,219 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $28,332,474 | 323,467 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $33,446,489 | 340,665 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||